Department of Cardiovascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
2 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a discovery-phase functional genomics screen that identifies candidate regulators of NLRP3 inflammasome activation in a cell line model; it raises mechanistic questions and nominates targets for future validation rather than testing a clinical hypothesis or providing evidence ready for therapeutic application.
Observational study with target trial emulation found no significant association between amino acid therapy and AKI, though hypothesis-generating subgroup signal in older patients.